Edmond de Rothschild Investment Partners has determined that bigger is better and thus is out raising a €200 million ($268.5 million) fourth life sciences venture fund that will be larger than its €156 million ($242.9 million) BioDiscovery 3 fund that closed in 2008.

Gilles Nobecourt of EdRIP told BioCentury that it would have been better if BioDiscovery 3 had had a couple of more portfolio companies, with slightly more allocated per investment. The firm has made 15 investments from BioDiscovery 3 and Nobecourt said it might do one